In addition, based on the interaction sequence between KIM1 and SARS-CoV-2, the team designed two polypeptides to block viral infection, among which AP2, a polypeptide consisting of 14 amino acids, can significantly reduce the aggregation of SARS-CoV-2 on the cell surface. Here, HAVCR1 is linked to viral infectious disease.